Results for

DEA Enforcement and Authority Act of 2019 This bill modifies enforcement authorities of the Drug Enforcement Administration (DEA). It modifies the required elements of an order to show cause issued by the DEA before it denies, revokes, or suspends a registration for a CSA violation. Specifically, the bill eliminates the requirement for an order to show cause to notify the registrant of the opportunity to submit a corrective action plan. Additionally, the bill modifies the standard of review for an immediate suspension order. Currently, the DEA may immediately suspend the registration of a controlled substances manufacturer, distributor, or dispenser to prevent imminent danger to the public health and safety. This bill lowers the standard for determining imminent danger to the public health and safety—from substantial likelihood of an immediate threat of harm to probable cause that harm will occur.

This resolution authorizes the use of the atrium in the Philip A. Hart Senate Office Building on April 22, 2020, for the National Prescription Drug Take Back Day, a semiannual event of the Drug Enforcement Administration.

This resolution authorizes the use of the atrium in the Philip A. Hart Senate Office Building on April 24, 2019, for the National Prescription Drug Take Back Day, a semiannual event of the Drug Enforcement Administration.

This resolution authorizes the use of the atrium in the Philip A. Hart Senate Office Building on October 23, 2019, for the National Prescription Drug Take Back Day, a semiannual event of the Drug Enforcement Administration.

Block, Report, And Suspend Suspicious Shipments Act of 2020 This bill creates additional requirements for drug manufacturers and distributors who discover a suspicious order for controlled substances. In addition to reporting the suspicious order to the Drug Enforcement Administration (DEA), a manufacturer or distributor must also exercise due diligence and decline to fill the order. The DEA must issue regulations specifying the indicators that give rise to a suspicious order.

This bill provides authority for the Drug Enforcement Administration to pay a cash award to an employee who maintains proficiency in a mission-critical language or who uses a foreign language in the performance of official duties.

Modernizing Drug Enforcement Act of 2019 This bill deems a drug or substance that acts as an opioid mu receptor agonist (e.g., morphine) to be in schedule I of the Controlled Substances Act, subject to certain exceptions. A schedule I controlled substance is a drug, substance, or chemical that has a high potential for abuse; has no currently accepted medical value; and is subject to regulatory controls and administrative, civil, and criminal penalties under the Controlled Substances Act.

Medical Marijuana Research Act of 2019 This bill establishes a new, separate registration process to facilitate medical marijuana research. Specifically, it directs the Drug Enforcement Administration to register (1) practitioners to conduct medical marijuana research, and (2) manufacturers and distributors to supply marijuana for such research. Additionally, the Department of Health and Human Services must continue to produce marijuana through the National Institute on Drug Abuse Drug Supply Program and offer to sell immature plants and seeds to researchers until manufacturers and distributors can provide a sufficient supply of marijuana for medical research.

Mainstreaming Addiction Treatment Act of 2019 This bill removes the requirement that a health care practitioner apply for a separate waiver through the Drug Enforcement Administration (DEA) to dispense certain narcotic drugs (e.g., buprenorphine) for maintenance or detoxification treatment (i.e., substance use disorder treatment). Further, a community health aide or community health practitioner may dispense certain narcotic drugs for maintenance or detoxification treatment without registering with the DEA if the drug is prescribed by a health care practitioner through telemedicine. It preempts state laws related to licensure for this activity. The bill also directs the Substance Abuse and Mental Health Services Administration to conduct a national campaign to educate health care practitioners and encourage them to integrate substance use disorder treatment into their practices.

Improving Confidence in Veterans' Care Act This bill addresses licensure and employment requirements for medical providers of the Department of Veterans Affairs (VA). Specifically, for VA medical provider positions that require a person to prescribe controlled substances, the bill prohibits a person from being employed if their Drug Enforcement Administration (DEA) registration has been terminated, revoked, or surrendered, and they have not received a waiver from the DEA. The bill also requires the VA to take prompt adverse personnel actions against a medical provider employee (1) who is not licensed, registered, certified, or in receipt of a DEA waiver; or (2) who does not promptly notify the VA of any suspension in such license, registration, or certification. Additionally, the VA must conduct biennial audits of medical provider employees to ensure they are licensed, registered, or certified as required. The VA shall ensure that the hiring process includes a request for licensure status and a verification of licensure status before an individual begins employment. Finally, the VA shall provide annual training on these licensure and employment requirements to directors of the Veterans Integrated Service Networks, as well as chiefs of staff and directors of VA health care facilities.

Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2021 This bill provides FY2021 appropriations for the Department of Agriculture (USDA), the Food and Drug Administration, and related agencies. The bill provides appropriations to USDA for Agricultural Programs, including * the Office of the Secretary, * Executive Operations, * the Economic Research Service, * the National Agricultural Statistics Service, * the Agricultural Research Service, * the National Institute of Food and Agriculture, * the Animal and Plant Health Inspection Service, * the Agricultural Marketing Service, and * the Food Safety and Inspection Service. The bill also provides appropriations to USDA for Farm Production and Conservation Programs, including * the Farm Production and Conservation Business Center, * the Farm Service Agency, * the Risk Management Agency, and * the Natural Resources Conservation Service. The bill provides appropriations to the Federal Crop Insurance Corporation Fund and the Commodity Credit Corporation Fund. For USDA Rural Development programs, the bill includes appropriations for * Rural Development Salaries and Expenses, * the Rural Housing Service, * the Rural Business-Cooperative Service, and * the Rural Utilities Service. The bill provides appropriations to the Food and Nutrition Service for * Child Nutrition Programs; * the Special Supplemental Nutrition Program for Women, Infants, and Children (WIC); * the Supplemental Nutrition Assistance Program (SNAP, formerly known as the food stamp program); * the Commodity Assistance Program; and * Nutrition Programs Administration. The bill provides appropriations to the Foreign Agricultural Service for (1) Food for Peace Title II Grants, and (2) McGovern-Dole International Food for Education and Child Nutrition Program Grants. The bill also provides appropriations for * the Food and Drug Administration, * the Commodity Futures Trading Commission, and * the Farm Credit Administration. Additionally, the bill sets forth requirements and restrictions for using funds provided by this and other appropriations Acts.

Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2020 This bill provides FY2020 appropriations for the Department of Agriculture (USDA), the Food and Drug Administration, and Related Agencies. The bill provides appropriations to USDA for Agricultural Programs, including * the Office of the Secretary, * Executive Operations, * the Office of the Chief Information Officer, * the Office of the Chief Financial Officer, * the Office of Civil Rights, * Agriculture Buildings and Facilities, * Hazardous Materials Management, * the Office of Inspector General, * the Office of the General Counsel, * the Office of Ethics, * the Economic Research Service, * the National Agricultural Statistics Service, * the Agricultural Research Service, * the National Institute of Food and Agriculture, * the Animal and Plant Health Inspection Service, * the Agricultural Marketing Service, and * the Food Safety and Inspection Service. The bill also provides appropriations to USDA for Farm Production and Conservation Programs, including * the Farm Production and Conservation Business Center, * the Farm Service Agency, * the Risk Management Agency, and * the Natural Resources Conservation Service. The bill provides appropriations to the Federal Crop Insurance Corporation Fund and the Commodity Credit Corporation Fund. For USDA Rural Development programs, the bill includes appropriations for * Rural Development Salaries and Expenses, * the Rural Housing Service, * the Rural Business-Cooperative Service, and * the Rural Utilities Service. Within the Food and Nutrition Service budget, the bill includes appropriations for * Child Nutrition Programs; * the Special Supplemental Nutrition Program for Women, Infants, and Children (WIC); * the Supplemental Nutrition Assistance Program (SNAP, formerly known as the food stamp program); * the Commodity Assistance Program; and * Nutrition Programs Administration. Within the Foreign Agricultural Service budget, the bill provides appropriations for Food for Peace Title II Grants and McGovern-Dole International Food for Education and Child Nutrition Program Grants. The bill also provides appropriations for * the Food and Drug Administration, * the Commodity Futures Trading Commission, and * the Farm Credit Administration. Additionally, the bill sets forth requirements and restrictions for using funds provided by this and other appropriations Acts.

Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2020 This bill provides FY2020 appropriations for the Department of Agriculture (USDA), the Food and Drug Administration, and Related Agencies. The bill provides appropriations to USDA for Agricultural Programs, including * the Office of the Secretary, * Executive Operations, * the Office of the Chief Information Officer, * the Office of the Chief Financial Officer, * the Office of Civil Rights, * Agriculture Buildings and Facilities, * Hazardous Materials Management, * the Office of Inspector General, * the Office of the General Counsel, * the Office of Ethics, * the Economic Research Service, * the National Agricultural Statistics Service, * the Agricultural Research Service, * the National Institute of Food and Agriculture, * the Animal and Plant Health Inspection Service, * the Agricultural Marketing Service, and * the Food Safety and Inspection Service. The bill also provides appropriations to USDA for Farm Production and Conservation Programs, including * the Farm Production and Conservation Business Center, * the Farm Service Agency, * the Risk Management Agency, and * the Natural Resources Conservation Service. The bill provides appropriations to the Federal Crop Insurance Corporation Fund and the Commodity Credit Corporation Fund. For USDA Rural Development programs, the bill includes appropriations for * Rural Development Salaries and Expenses, * the Rural Housing Service, * the Rural Business-Cooperative Service, and * the Rural Utilities Service. Within the Food and Nutrition Service budget, the bill includes appropriations for * Child Nutrition Programs; * the Special Supplemental Nutrition Program for Women, Infants, and Children (WIC); * the Supplemental Nutrition Assistance Program (SNAP, formerly known as the food stamp program); * the Commodity Assistance Program; and * Nutrition Programs Administration. Within the Foreign Agricultural Service budget, the bill provides appropriations for Food for Peace Title II Grants and McGovern-Dole International Food for Education and Child Nutrition Program Grants. The bill also provides appropriations for the Food and Drug Administration and the Farm Credit Administration. Additionally, the bill sets forth requirements and restrictions for using funds provided by this and other appropriations Acts.

This bill provides for approval of the application submitted by Jaci Hermstad to the Food and Drug Administration for compassionate use of the gene therapy antisense oligonucleotides.

Lowering Prescription Drug Prices for America's Seniors and Families Act of 2020 This bill makes a series of changes to requirements relating to prescription drug prices. Among other changes, the bill requires the Centers for Medicare & Medicaid Services to negotiate the prices of certain covered drugs under the Medicare prescription drug benefit, allows individuals to import certain drugs from Canada to fill personal prescriptions, and establishes specific enforcement actions against patent infringement agreements that involve generic drug manufacturers and have anticompetitive effects.

Preventing Opioid and Drug Impairment in Transportation Act This bill addresses drug and alcohol testing for transportation-related activities. Specifically, the bill requires * the National Railroad Passenger Corporation (Amtrak) to report on methods it uses to ensure supervisors of employees in safety-sensitive positions receive the required training on how to detect drug and alcohol use; * the Department of Transportation (DOT) to determine whether to mandate that Amtrak locomotive engineers and conductors report arrests due to drug or alcohol offenses; * DOT to report on the ability of pipeline companies that operate from Canada or Mexico into the United States to conduct the same drug and alcohol tests of safety-sensitive personnel that are required in the United States; * DOT to amend its auditing program to improve the efficiency of certain drug and alcohol regulations related to testing contractors working in multiple states; * the National Highway Traffic Safety Administration to study the ways it can reduce and better detect impaired driving, including marijuana- and opioid-impaired driving; * DOT to conduct a study regarding the accuracy of on-site oral fluid screening for tetrahydrocannabinol and opiate presence in order to reduce the potential impact on traffic safety due to drug and polysubstance-impaired drivers; * the Government Accountability Office to review DOT's process for setting guidelines and drug testing requirements for transportation employees; and * reports on whether to add fentanyl to the drug testing panel and the status of the guidelines for hair testing of transportation employees.

Safe Drugs Act This bill authorizes the Food and Drug Administration (FDA) to order the mandatory recall of any drug when the FDA determines that there is a reasonable probability that the drug would cause serious adverse health consequences or death. Currently, the FDA may order a mandatory recall under such circumstances only with respect to a controlled substance.

Affordable and Safe Prescription Drug Importation Act This bill addresses the importation of drugs from Canada and other foreign countries. The bill requires the Food and Drug Administration (FDA) to promulgate regulations within 180 days permitting wholesalers, pharmacies, and individuals to import certain prescription drugs from Canada. After two years, The FDA, may permit the importation of prescription drugs from other countries. The bill establishes a process for certifying foreign sellers—a licensed foreign pharmacy or foreign wholesale distributor.

Affordable and Safe Prescription Drug Importation Act This bill addresses the importation of drugs from Canada and other foreign countries. The bill requires the Food and Drug Administration (FDA) to promulgate regulations within 180 days permitting wholesalers, pharmacies, and individuals to import certain prescription drugs from Canada. After two years, The FDA, may permit the importation of prescription drugs from other countries. The bill establishes a process for certifying foreign sellers—a licensed foreign pharmacy or foreign wholesale distributor.

Preventing Pharmacy Robbery Act of 2019 This bill requires the Drug Enforcement Administration to disseminate best practices and strategies for responding to the attempted robbery of a pharmacy.

Preventing Drug Shortages Act This bill expands existing manufacturer reporting requirements related to shortages of life-saving drugs and contains other related provisions. The bill requires a manufacturer of an active pharmaceutical ingredient of a life-saving drug to notify the Food and Drug Administration (FDA) of an interruption that is likely to lead to a meaningful disruption in the ingredient's supply, whereas under current law this requirement generally applies only to the manufacturer of a life-saving drug that faces a supply disruption. The notification must contain specified information, including any alternative sources for the ingredient. The bill also requires a manufacturer of a life-saving drug or an active pharmaceutical ingredient for such a drug to include in its annual product registration the specific facilities where the drug or ingredient is manufactured. The FDA may also require the manufacturer to conduct periodic risk assessments to address vulnerabilities in its supply chain. The Government Accountability Office shall report to Congress on the FDA's intra-agency coordination in assessing drug shortage risks.